Literature DB >> 24606938

A flexible docking scheme efficiently captures the energetics of glycan-cyanovirin binding.

Ashini Bolia1, Brian W Woodrum1, Angelo Cereda1, Melissa A Ruben1, Xu Wang1, S Banu Ozkan2, Giovanna Ghirlanda3.   

Abstract

Cyanovirin-N (CVN), a cyanobacterial lectin, exemplifies a class of antiviral agents that inhibit HIV by binding to the highly glycosylated envelope protein gp120. Here, we investigate the energetics of glycan recognition using a computationally inexpensive flexible docking approach, backbone perturbation docking (BP-Dock). We benchmarked our method using two mutants of CVN: P51G-m4-CVN, which binds dimannose with high affinity through domain B, and CVN((mutDB)), in which binding to domain B has been abolished through mutation of five polar residues to small nonpolar side chains. We investigated the energetic contribution of these polar residues along with the additional position 53 by docking dimannose to single-point CVN mutant models. Analysis of the docking simulations indicated that the E41A/G and T57A mutations led to a significant decrease in binding energy scores due to rearrangements of the hydrogen-bond network that reverberated throughout the binding cavity. N42A decreased the binding score to a level comparable to that of CVN((mutDB)) by affecting the integrity of the local protein structure. In contrast, N53S resulted in a high binding energy score, similar to P51G-m4-CVN. Experimental characterization of the five mutants by NMR spectroscopy confirmed the binding affinity pattern predicted by BP-Dock. Despite their mostly conserved fold and stability, E41A, E41G, and T57A displayed dissociation constants in the millimolar range. N53S showed a binding constant in the low micromolar range, similar to that observed for P51G-m4-CVN. No binding was observed for N42A. Our results show that BP-Dock is a useful tool for rapidly screening the relative binding affinity pattern of in silico-designed mutants compared with wild-type, supporting its use to design novel mutants with enhanced binding properties.
Copyright © 2014 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24606938      PMCID: PMC4026791          DOI: 10.1016/j.bpj.2014.01.040

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  55 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures.

Authors:  Laura G Barrientos; John M Louis; Istvan Botos; Toshiyuki Mori; Zhaozhong Han; Barry R O'Keefe; Michael R Boyd; Alexander Wlodawer; Angela M Gronenborn
Journal:  Structure       Date:  2002-05       Impact factor: 5.006

Review 3.  Cyanovirin-N: a sugar-binding antiviral protein with a new twist.

Authors:  I Botos; A Wlodawer
Journal:  Cell Mol Life Sci       Date:  2003-02       Impact factor: 9.261

Review 4.  Flexible ligand docking to multiple receptor conformations: a practical alternative.

Authors:  Maxim Totrov; Ruben Abagyan
Journal:  Curr Opin Struct Biol       Date:  2008-02-25       Impact factor: 6.809

Review 5.  Using chemical shift perturbation to characterise ligand binding.

Authors:  Mike P Williamson
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2013-03-21       Impact factor: 9.795

6.  Anti-HIV activity of defective cyanovirin-N mutants is restored by dimerization.

Authors:  Elena Matei; Andrew Zheng; William Furey; Jeremy Rose; Christopher Aiken; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

7.  Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.

Authors:  T Mori; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

8.  Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 A resolution.

Authors:  Raimund Fromme; Zivile Katiliene; Petra Fromme; Giovanna Ghirlanda
Journal:  Protein Sci       Date:  2008-05       Impact factor: 6.725

9.  Computational study of the conformational structures of saccharides in solution based on J couplings and the "fast sugar structure prediction software".

Authors:  Junchao Xia; Claudio J Margulis
Journal:  Biomacromolecules       Date:  2009-11-09       Impact factor: 6.988

View more
  5 in total

1.  The Role of Conformational Dynamics and Allostery in the Disease Development of Human Ferritin.

Authors:  Avishek Kumar; Tyler J Glembo; S Banu Ozkan
Journal:  Biophys J       Date:  2015-08-06       Impact factor: 4.033

Review 2.  Recent advances in employing molecular modelling to determine the specificity of glycan-binding proteins.

Authors:  Oliver C Grant; Robert J Woods
Journal:  Curr Opin Struct Biol       Date:  2014-08-07       Impact factor: 6.809

3.  Development and Evaluation of GlycanDock: A Protein-Glycoligand Docking Refinement Algorithm in Rosetta.

Authors:  Morgan L Nance; Jason W Labonte; Jared Adolf-Bryfogle; Jeffrey J Gray
Journal:  J Phys Chem B       Date:  2021-06-16       Impact factor: 2.991

4.  A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity.

Authors:  Brian W Woodrum; Jason Maxwell; Denysia M Allen; Jennifer Wilson; Lauren R H Krumpe; Andrey A Bobkov; R Blake Hill; Karen V Kibler; Barry R O'Keefe; Giovanna Ghirlanda
Journal:  Viruses       Date:  2016-06-06       Impact factor: 5.048

5.  A detailed picture of a protein-carbohydrate hydrogen-bonding network revealed by NMR and MD simulations.

Authors:  Gustav Nestor; Alessandro Ruda; Taigh Anderson; Stefan Oscarson; Göran Widmalm; Angela M Gronenborn
Journal:  Glycobiology       Date:  2021-05-03       Impact factor: 4.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.